Companies: 10,795·Total market cap: $144.5T
Cresco Labs Inc.

Cresco Labs Inc.

CL.CNCNQHealthcare● Active
$1.29
+$0.05(+4.03%)
Market Cap$456950989
P/E Ratio
52W High$3.12
52W Low$0.6

Cresco Labs Inc.(CL.CN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CL.CN · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.67B$0.72B$0.77B$0.84B$0.82B
Cost of Revenue$0.33B$0.36B$0.41B$0.44B$0.42B
Gross Profit$0.32B$0.36B$0.36B$0.41B$0.41B
Gross Margin %(computed)48.64%50.32%47.01%48.30%49.45%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$0.23B$0.27B$0.05B$0.04B
Total Operating Expenses$0.25B$0.26B$0.45B$0.49B$0.62B
Operating Income$0.08B$0.11B($0.09B)($0.08B)($0.22B)
Operating Margin %(computed)11.53%14.81%-11.39%-10.00%-26.45%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.06B$0.06B$0.06B$0.06B$0.05B
Income Before Tax($0.10B)($0.01B)($0.15B)($0.13B)($0.26B)
Income Tax Expense$0.04B$0.05B$0.03B$0.09B$0.04B
Net Income($0.14B)($0.07B)($0.18B)($0.21B)($0.32B)
Net Margin %(computed)-20.65%-10.28%-22.77%-25.16%-38.90%
Per Share & EBITDA
EPS (Basic)$-0.42$-0.22$-0.53$-0.71$-1.22
Wtd Avg Shares0.34B0.35B0.32B0.30B0.26B
EBITDA$0.02B$0.11B($0.01B)($0.01B)($0.16B)
EBITDA Margin %(computed)3.05%15.78%-1.81%-1.27%-19.43%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Cresco Labs Inc.

关于Cresco Labs Inc.(CL.CN)损益表

Cresco Labs Inc.(CL.CN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CL.CN实现营收$0.67B,毛利润$0.32B(毛利率48.64%),净利润($0.14B)(净利率-20.65%)。

常见问题

CL.CN · 4 问

Cresco Labs Inc.(CL.CN)2025财年营收为$0.67B,同比down7.9%。

CL.CN revenueCL.CN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08